United Therapeutics Corporation (UTHR)
BENKOWITZ MICHAEL 🟡 adjusted position in 22.5K shares (3 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $417.50 ($15.7M) Transaction Date: Oct 27, 2025 | Filing ID: 000009
BENKOWITZ MICHAEL 🟡 adjusted position in 22.5K shares (3 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $417.50 ($15.7M) Transaction Date: Oct 27, 2025 | Filing ID: 000009
🔍 BENKOWITZ MICHAEL (Executive)
Company: UNITED THERAPEUTICS Corp (UTHR)
Report Date: 2025-10-27
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2025-10-27 | Code: M | equity_swap_involved: false | shares_owned_after: 14,625.00 | transaction_form_type: 4 | Footnotes: F1, F2
Date: 2025-10-27 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2
Date: 2025-10-27 | Code: M | equity_swap_involved: false | shares_owned_after: 6,125.00 | transaction_form_type: 4 | Footnotes: F1, F3
Date: 2025-10-27 | Code: M | equity_swap_involved: false | shares_owned_after: 7,875.00 | transaction_form_type: 4 | Footnotes: F1, F3
Date: 2025-10-27 | Code: S | equity_swap_involved: false | shares_owned_after: 130.00 | transaction_form_type: 4 | Footnotes: F1, F3
Date: 2025-10-27 | Code: H | shares_owned_after: 2,648.00
Date: 2025-10-27 | Code: M | Expires: 2026-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 55,875.00 | transaction_form_type: 4 | Footnotes: F1, F2
Date: 2025-10-27 | Code: M | Expires: 2026-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 18,375.00 | transaction_form_type: 4 | Footnotes: F1, F3
Date: 2025-10-27 | Code: M | Expires: 2027-03-15 | Exercise: 2018-03-15 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F3
Footnotes: